Alzheimer's Disease Trial, Recruiting (NCT05205980)

Alzheimer's Disease Trial, Recruiting NCT05205980 Sponsor: Georgia State University Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05205980 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be at least 65 years old
You have been diagnosed with probable Alzheimer's disease
You can read and understand English
You are able to walk at least 25 feet on your own without help
You are able to stand on your own for at least 30 seconds without help
You have scored between 11 and 21 on a standard memory and thinking test called the Montreal Cognitive Assessment, or between 18 and 23 on a similar test called the Mini Mental Status Examination

Who may not be able to join:

You have previously taken part in a type of balance training that involves being pushed or pulled off balance (called perturbation training)
You have low blood pressure or high blood pressure that is not well controlled by treatment
You have been diagnosed with osteoporosis (a condition that weakens the bones)
You have another mental health condition, a neurological condition (a condition affecting the brain or nervous system), or other injuries or health conditions alongside your Alzheimer's diagnosis (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Feng Yang, PhD, Georgia State University

Phone: 404-413-8357

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05205980

Sponsor: Georgia State University

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 404-413-8357

More information: https://clinicaltrials.gov/study/NCT05205980

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be at least 65 years old
You have been diagnosed with probable Alzheimer's disease
You can read and understand English
You are able to walk at least 25 feet on your own without help
You are able to stand on your own for at least 30 seconds without help
You have scored between 11 and 21 on a standard memory and thinking test called the Montreal Cognitive Assessment, or between 18 and 23 on a similar test called the Mini Mental Status Examination

Who may not be able to join:

You have previously taken part in a type of balance training that involves being pushed or pulled off balance (called perturbation training)
You have low blood pressure or high blood pressure that is not well controlled by treatment
You have been diagnosed with osteoporosis (a condition that weakens the bones)
You have another mental health condition, a neurological condition (a condition affecting the brain or nervous system), or other injuries or health conditions alongside your Alzheimer's diagnosis (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Georgia State University

Registry

ClinicalTrials.gov

Start date

28 April 2023

Est. completion

30 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Lab-induced faller rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov